AOP Orphan Pharmaceuticals has announced the spin-off of its 80% stake in Activartis, a Vienna-based biotech company, to a group of private investors. Activartis has developed dendritic cell-based technology for individualized tumor ...
Tags: AOP Orphan, Medicine